Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls

    Brianna Olamiju, Brittany G. Craiglow
    Image of study
    TLDR Minoxidil and spironolactone improve hair density and reduce shedding in girls.
    The article discusses the use of combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females. The study found that the combination therapy was effective in improving hair density and reducing hair shedding in the majority of patients. The treatment was well-tolerated with no significant adverse effects reported. The authors suggest that this combination therapy may be a viable option for the treatment of androgenetic alopecia in adolescent females.
    View this study on jaad.org →

    Cited in this study

    Related